Skip to main content

Table 1 Patients’ characteristics

From: Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial

Patients’ characteristics (n = 79)

n (%)a

Age (years)

64 [38–82]

Sex

 Male

48 (61)

 Female

31 (39)

ECOG-PS score

 0

37 (47)

 1

40 (49)

Primary tumor site

 Colon

61 (71)

 Rectum

25 (29)

Metastases

 Synchronous

61 (77)

 Metachronous

18 (23)

Chemotherapy regimen

 FOLFIRI

56 (71)

 FOLFOX

5 (6)

 LV5FU2

7 (9)

 Other

11 (14)

LDH (UI/L)

750 [111–3510]

CEA (ng/mL)

625 [1–6013]

  1. ECOG-PS Eastern Cooperative Oncology Group—Performance Status, LDH Lactate dehydrogenase, CEA Carcinoembryonic antigen
  2. aExcept for age, LDH and CEA that are reported as medians [SD]